Horizon Pharma plc to Participate in the Morgan Stanley 16th Annual Global Healthcare Conference
September 04 2018 - 8:00AM
Business Wire
Horizon Pharma plc (Nasdaq: HZNP) announced today that the
company will participate in the following conference:
Morgan Stanley 16th Annual Global Healthcare
Conference
- Date: Sept. 13, 2018
- Presentation Time: 10:35 a.m. ET
- Location: New York, NY
The presentation will be webcast live and may be accessed by
visiting Horizon's website at http://ir.horizon-pharma.com. A
replay of the webcast will be available for the event.
About Horizon Pharma plc
Horizon Pharma plc is focused on researching,
developing and commercializing innovative medicines that address
unmet treatment needs for rare and rheumatic diseases. By fostering
a growing pipeline of medicines in development and exploring all
potential uses for currently marketed medicines, we strive to make
a powerful difference for patients, their caregivers and
physicians. For us, it’s personal: by living up to our own
potential, we are helping others live up to theirs. For more
information, please visit www.horizonpharma.com, follow us @HZNPplc
on Twitter or like us on Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180904005080/en/
Horizon PharmaInvestors:Tina VenturaSenior Vice
President,Investor
Relationsinvestor-relations@horizonpharma.comorRuth
VenningExecutive Director,Investor
Relationsinvestor-relations@horizonpharma.comorU.S.
Media:Geoff CurtisExecutive Vice President,Corporate Affairs
& Chief Communications Officermedia@horizonpharma.comorIreland Media:Ray
GordonGordon MRMray@gordonmrm.ie
Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart
From Apr 2023 to Apr 2024